| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |